Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type I Diabetes III: Clinical Manifestations

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dopamine 2 and somatostatin 1-5 receptors coexpression in clinically non-functioning pituitary adenomas.

Physiological research·2014

Same author

The PRIMARA study: a prospective, descriptive, observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practice.

European journal of endocrinology·2014

Same author

Results of retrospective classification of thyroid FNAs according to the Bethesda system: would this have improved accuracy?

Cytopathology : official journal of the British Society for Clinical Cytology·2014

Same author

[Recommendation of the Czech Society of Endocrinology for the treatment of Cushing's syndrome in adults].

Vnitrni lekarstvi·2013

Same author

The effect of immunosuppression on manifestations of sepsis in an animal model of cecal ligation and puncture.

Transplantation proceedings·2013

Same author

[Incretin hormones].

Vnitrni lekarstvi·2011

Search research articles

Related Experiment Video

Updated: May 23, 2026

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas

Published on: November 11, 2025

[Androgen deficit and diabetes].

¹II. Interní Klinika Lékarské Fakulty UK a FN Králové, Prednosta prof. MUDr. Jaroslav Malý, CSc. capj@ifhk.cuni.cz

Vnitrni Lekarstvi

|April 11, 2012

Summary

Low testosterone is common in obese men with type 2 diabetes. Testosterone replacement therapy can improve libido and erectile dysfunction, especially when combined with other treatments.

Area of Science:

Endocrinology
Metabolic Syndrome

Context:

Obesity and type 2 diabetes mellitus are prevalent conditions associated with hormonal imbalances.
Low testosterone levels (hypogonadism) are frequently observed in these patient populations.
The interplay between obesity, diabetes, inflammation, and testosterone is complex and not fully understood.

Purpose:

To explore the causes and consequences of low testosterone in men with type 2 diabetes.
To evaluate the indications and efficacy of testosterone substitution therapy in this group.
To clarify the role of testosterone in metabolic health and mortality.

Summary:

Low testosterone is common in obese men, particularly those with type 2 diabetes.
Factors like inflammation, insulin resistance, leptin resistance, and low SHBG are more significant than aromatization.

More Related Videos

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

Related Experiment Videos

Last Updated: May 23, 2026

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas

Published on: November 11, 2025

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

Symptoms include low libido, erectile dysfunction, fatigue, and depression; it's linked to anemia, osteoporosis, worsened insulin resistance, and increased mortality.

Routine testosterone testing is recommended for men with type 2 diabetes.

Testosterone therapy is indicated for symptomatic hypogonadism, improving libido more than erectile dysfunction, but enhancing PDE5 inhibitor efficacy.

Impact:

Highlights the importance of screening for low testosterone in diabetic men.
Provides guidance on testosterone replacement therapy indications and expected outcomes.
Suggests testosterone deficiency may be a marker for increased mortality risk in this population.